Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-08

Clinical Trial Update: The HEP-OKS Study - Hemifield Eye Patching and Optokinetic Stimulation to Treat Hemispatial Neglect in Stroke Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hemifield eye patching and optokinetic stimulation to treat hemispatial neglect in stroke patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Luebeck | Conditions: Spatial Neglect, Cerebral Stroke | Phase 3 | Status: COMPLETED